Shijiazhuang Yiling Pharmaceutical Co Ltd (002603) — Financial Flexibility Index
Shijiazhuang Yiling Pharmaceutical Co Ltd (002603) has a Financial Flexibility Index of 0.15x as of September 2025. Free cash flow of CN¥530.90 Million (operating CF CN¥446.51 Million minus capex CN¥84.38 Million) represents 0% of total liabilities (CN¥3.52 Billion). Check 002603 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Shijiazhuang Yiling Pharmaceutical Co Ltd Financial Flexibility Index (2008–2025)
Historical Financial Flexibility Index trend for Shijiazhuang Yiling Pharmaceutical Co Ltd across 18 annual periods. For the full cash flow conversion analysis, see Shijiazhuang Yiling Pharmaceutical Co Lt cash flow conversion.
Annual Financial Flexibility Index for Shijiazhuang Yiling Pharmaceutical Co Ltd (2008–2025)
Year-by-year free cash flow to debt coverage for Shijiazhuang Yiling Pharmaceutical Co Ltd. Explore Shijiazhuang Yiling Pharmaceutical Co Lt (002603) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.75x | CN¥2.02 Billion | CN¥1.78 Billion | CN¥2.69 Billion | ▲ +159.6% |
| 2024 | 0.29x | CN¥901.40 Million | CN¥611.01 Million | CN¥3.12 Billion | ▲ +243.7% |
| 2023 | 0.08x | CN¥466.29 Million | CN¥155.46 Million | CN¥5.54 Billion | ▼ -87.7% |
| 2022 | 0.68x | CN¥3.70 Billion | CN¥3.49 Billion | CN¥5.41 Billion | ▲ +118.1% |
| 2021 | 0.31x | CN¥1.20 Billion | CN¥528.69 Million | CN¥3.83 Billion | ▼ -70.3% |
| 2020 | 1.06x | CN¥2.73 Billion | CN¥1.59 Billion | CN¥2.58 Billion | ▲ +125.5% |
| 2019 | 0.47x | CN¥523.35 Million | CN¥68.93 Million | CN¥1.12 Billion | ▲ +79.3% |
| 2018 | 0.26x | CN¥259.59 Million | CN¥72.37 Million | CN¥993.56 Million | ▼ -31.3% |
| 2017 | 0.38x | CN¥295.00 Million | CN¥114.65 Million | CN¥775.58 Million | ▼ -65.3% |
| 2016 | 1.10x | CN¥1.01 Billion | CN¥641.45 Million | CN¥925.04 Million | ▲ +58.0% |
| 2015 | 0.69x | CN¥610.31 Million | CN¥131.88 Million | CN¥879.56 Million | ▼ -16.3% |
| 2014 | 0.83x | CN¥556.10 Million | CN¥105.90 Million | CN¥671.19 Million | ▼ -28.8% |
| 2013 | 1.16x | CN¥465.15 Million | CN¥55.32 Million | CN¥399.69 Million | ▲ +1.7% |
| 2012 | 1.14x | CN¥367.02 Million | CN¥70.13 Million | CN¥320.75 Million | ▲ +359.9% |
| 2011 | -0.44x | CN¥-230.59 Million | CN¥-408.49 Million | CN¥523.78 Million | ▼ -151.2% |
| 2010 | 0.86x | CN¥584.74 Million | CN¥299.72 Million | CN¥680.08 Million | ▲ +16.9% |
| 2009 | 0.74x | CN¥528.78 Million | CN¥318.21 Million | CN¥718.89 Million | ▼ -24.4% |
| 2008 | 0.97x | CN¥338.45 Million | CN¥210.18 Million | CN¥347.88 Million | — |